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Abstract. Nerve growth factor (NGF)-mediated neu- 
rite outgrowth in rat pheochromocytoma PC 12 cells 
has been described to be synergistically potentiated by 
the simultaneous addition of dibutyryl cAMP. To elu- 
cidate further the role of cAMP in NGF-induced neu- 
rite outgrowth we have used the adenylate cyclase ac- 
tivator forskolin, cAMP, and a set of chemically mod- 
ified cAMP analogues, including the adenosine cyclic 
3',5'-phosphorothioates (cAMPS) (Rp)-cAMPS and 
(Sp)-cAMPS. These diastereomers have differential ef- 
fects on the activation of cAMP-dependent protein 
kinases, i.e., (Sp)-cAMPS behaves as a cAMP agonist 
and (Rp)-cAMPS behaves as a cAMP antagonist. Our 
data show that the establishment of a neuritic net- 
work, as observed from PC 12 cells treated with NGF 
alone, could not be induced by either forskolin, 
cAMP, or cAMP analogues alone. The presence of 
NGF in combination with forskolin or cAMP or its 
agonistic analogues potentiated the initiation of neu- 
rite outgrowth from PC 12 cells. The (Sp)-cAMPS-in- 
duced stimulation of NGF-mediated process forma- 
tion was successfully blocked by the (Rp)-cAMPS 
diastereomer. On the other hand, NGF-stimulated 
neurite outgrowth was not inhibited by the presence 
of the cAMP antagonist (Rp)-cAMPS. We conclude 
that the morphological differentiation of PC12 cells 
stimulated by NGF does not require cAMP as a sec- 
ond messenger. The constant increase of intracellular 
cAMP, caused by either forskolin or cAMP and the 
analogues, in combination with NGF, not only rap- 
idly stimulated early neurite outgrowth but also ex- 
erted a maintaining effect on the neuronal network 
established by NGF. 
T 
HE polypeptide hormone nerve growth factor (NGF)' 
is involved in the development and maintenance  of 
sympathetic and certain sensory neurons (21) and is 
also required for the growth, survival, and differentiation of 
primary cultures of  sympathetic neurons (35). Although many 
effects of  NGF in its target cells have been extensively  studied, 
its molecular mechanisms of action are far from understood 
(8). The PCI2 clonal line of rat pheochromocytoma cells has 
become a useful model system for studying the mechanism 
of  action of  NGF (9). PC 12 cells respond to NGF by acquiring 
many properties of sympathetic neurons; among these, they 
extend long neuritic processes and cease cell division (9). The 
morphological differentiation to the neuron-like phenotype, 
e.g., the initiation  of neurite outgrowth, is a transcription- 
dependent process and presumably requires the synthesis of 
gene products (3). PC12 cells that have been exposed to NGF 
for the first time require up to a week until most of the cells 
have extended neuritic  processes (9). However, a "priming 
mechanism" has been described. When PC 12 cells pretreated 
with  NGF  for  7-10  d  are  divested of their  processes by 
mechanical disruption and then replated in the presence of 
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CIcAMP,  6-chloropurineriboside;  GAB,  l-N-oxide-adenosine cAMP; HPLC, 
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8-p-chlorophenylthio  cAMP. 
NGF they will regenerate their neurites within 24 h (3,  10). 
This neurite regeneration, as opposed to neurite  initiation 
from "naive" ceils, does not require RNA or protein synthesis 
(3). Thus, Greene et al. (10) have suggested that priming of 
PC 12 cells causes the specific stimulation of a transcription- 
dependent  synthesis and  accumulation  of material  which 
enables the cells to produce neuritic processes. 
It has been discussed that the NGF-responses in PC 12 cells 
are mediated through cAMP. This assumption was mainly 
based on the observations that (a)  NGF increased cAMP 
content in PC 12 cells during the first minutes after exposure 
(32, 33); (b) cAMP and NGF modulate the synthesis of the 
same set of proteins (6); and (c) dibutyryl cAMP (BhcAMP) 
and NGF produce basically the same phosphorylation pat- 
terns in PC12 cells (15, 29, 38). However, PC12 cells cannot 
be  primed  by  Bt2cAMP (10, 14,  16), and  NGF-induced 
changes in cellular RNA and protein levels and cellular mor- 
phology were different from those induced by Bt2cAMP (13, 
14). In addition, the induction  of a high molecular weight 
microtubule-associated  phosphoprotein was regulated only by 
NGF and not by Bt2cAMP (12). Thus, Greene et al. (11) were 
the first to suggest that NGF and cAMP elicit neurite out- 
growth by different mechanisms. 
To clarify further the role of  cAMP in NGF-induced neurite 
outgrowth from PC 12  cells we have used a set of selected 
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applied the (Rp) and (Sp) diastereomeres of adenosine 3',5'- 
phosphorothioate (cAMPS) (Fig.  1), which are known to act 
differentially on the activation of cAMP-dependent protein 
kinases (4,  5,  24).  (Sp)-cAMPS had an activating effect on 
cAMP-dependent protein kinases (types I and II), whereas the 
highly purified (Rp)-cAMPS isomer did not activate but rather 
inhibited protein kinases, thus behaving as a cAMP antagonist 
(28, 30, 31). Therefore, (Rp)-cAMPS provides a useful means 
with which to investigate cAMP-mediated effects in neuronal 
differentiation of cultured cells. In addition, we have studied 
the effect of forskolin, a diterpene known as a potent activator 
of  adenylate cyclase (34), on the morphological differentiation 
of PC12 cells. 
Materials and Methods 
Forskolin was purchased from Calbiochem-Behring (Frankfurt,  FRG). cAMP 
and its analogues were from Boehringer (Mannheim,  FRG). (Rp)-cAMPS and 
(Sp)-cAMPS were synthesized in our laboratory as described before (1,  18, 22, 
23).  All  analogues  used  contained  <0.5%  cAMP  as  determined  by  high- 
performance liquid chromatography  (HPLC). The (Rp)-cAMPS derivative was 
specifically purified and contained <0.01% of either cAMP or the (Sp)-cAMPS 
diastereomer.  Tissue culture media were from Boehringer. 
Reversed-Phase HPLC 
HPLC  for determining  cyclic nucleotides in the growth medium was carried 
out as described by Braumann and Jastorff (2). PCI2 cells were cultured  on 
35-mm-diam plates (2 x  105 cells/dish) and (Sp)- or (Rp)-cAMPS (1 mM) was 
added at day 0. Aliquots of the cell supernatant  were analyzed every 24 h. 
Cell Culture 
l°Cl 2 ceils (passages 30-40)  were grown as described by Greene and Tischler 
(9) on collagen-coated tissue culture dishes either with or without NGF (50 ng/ 
ml) in complete  medium consisting of 85%  RPMI  1640, 10%  horse serum, 
and 5% fetal calf serum. The content  of confluent  culture (10-cm diam) was 
transferred to 20 plates (35-ram  diam), and fresh medium containing  cAMP 
analogues or forskolin as indicated was added  24-48  h after plating. Growth 
medium supplemented with the compounds was added every 2-3 d. Cells were 
viewed and photographed using a Zeiss ICM 405 inverted microscope with an 
automatic camera. 
Quantitation of  Neurite Outgrowth 
The morphological differentiation  of PCI2 cells was assayed by determining 
the percentage of neurite-bearing cells. Subconfluent cultures were recultured 
at 1-2 ×  104 cells per cm  2. After 1-2 d fresh medium supplemented with NGF 
or/and cAMP or its analogues was added. Culture medium was changed every 
2-3 d with the  addition  of fresh NGF and cAMP derivatives. Small clumps 
with  neuritic  processes longer than one cell body  diameter  were scored. A 
minimum of 300 clumps per culture  were examined  by strip  counting.  All 
experiments were performed at least three times. Variations were <5%. 
Results 
Effects of  cAMP Analogues on Neurite Formation 
In  PC12  cells the initiation of neurite outgrowth could be 
potentiated by the simultaneous addition of Bt2cAMP  and 
NGF (11,  13, 39). Most of the studies on the role of cAMP 
in NGF-induced neurite outgrowth have been carried out by 
using  Bt2cAMP,  a  double-modified  cAMP  analogue. 
Bt2cAMP has to be metabolically activated before binding to 
cAMP  receptor proteins (20),  and  butyric acid  is  released 
during the metabolic activation. To exclude cAMP nonrelated 
unspecific effects caused by the metabolites, we have used a 
set  of chemically modified cAMP derivatives that directly 
bind to protein kinases, mainly: 2'-0-monobutyryl  cAMP (2'- 
A 
--" (Sp) - isomer) 
o 
0 ~P:  0 
t  OH 
S  (equotoriol -~ (Rp)-isomer) 
Figure 1. Chemical structure of the phosphorothioate analogues of 
cAMP. 
0-BtcAMP),  6-chloropurineriboside cAMP  (6-CIcAMP),  8- 
bromoadenosine cAMP  (8-BrcAMP),  8-p-chlorophenylthio 
cAMP (8-PCTP),  1-N-oxide-adenosine cAMP (GAB), aden- 
osine-3',5'-phosphorothioates (Sp)  and  (Rio) [(Sp)-cAMPS 
and (Rp}-cAMPS]  (Fig.  1), and, for comparison, Bt2cAMP. 
The exposure of PC 12 cells to cAMP analogues at concentra- 
tions of up to 10  -3 M did not produce neurite formation, yet 
some of the derivatives, e.g., Bt2cAMP, 6-C1 cAMP (Fig. 2), 
GAB, and (Sp)-cAMPS (not shown), initiated the production 
of short processes, as has been described for Bt:cAMP before 
(13,  16). However, these processes did not continue to grow 
to form a  network, even when cells were treated with high 
concentrations of cAMP analogues (10  -3 M) for up to 6 to 8 
d (Fig. 3, b and c). NGF (50 ng/ml) initiated neurite outgrowth 
in PC12 cells progressively. After 2 d only 20-30% of  the cells 
were neurite bearing,  and  maximal response was  achieved 
only after 6-8  d  in  culture (Fig.  2)  (9).  The simultaneous 
addition of NGF and cAMP analogues caused a more rapid 
increase in neurite initiation than did NGF alone (Fig. 2, d- 
i). 
All analogues known to act as cAMP agonists in combina- 
tion with NGF induced a degree of early neurite formation 
by far exceeding the effect of NGF or cAMP analogues alone. 
As  shown  in  Fig.  4  after 2-3  d  50-80%  of the  cells  had 
produced long neurites, and elaborated a branched neuronal 
network (Fig. 2, e-i). Treatment with GAB was revealed to 
be toxic after 2-3 d, and the application of 8-PCTP to low 
density cultures caused the cells to clump, making impossible 
the quantitative evaluation beyond day 3 in culture (Fig. 4, 
C). In cultures treated with NGF and 8-BrcAMP many giant 
cells with long branched processes were observed (Fig.  2 h, 
center). The addition of cCMP or cGMP analogues to the 
NGF-containing culture medium did not cause marked stim- 
ulation of  process outgrowth, as shown for 8-BrcGMP in Fig. 
4B. Half maximal stimulation of neurite outgrowth occurred 
at ~2 ×  10  -6 M for 2'-0-monobutyryl cAMP, and 2 ×  10  -5 
M  for dibutyryl cAMP  and  (Sp)-cAMPS,  maximal effects 
were reached at 10  -3 M for all three agents. 
Effect of cAMP 
cAMP analogues, especially Bt2cAMP, are widely used in cell 
biology since it is believed that Bt2cAMP  more easily pene- 
trates cell membranes and is more resistant to hydrolysis by 
cAMP phosphodiesterase than  cAMP  itself (25).  We  have 
added cAMP to the growth medium of PC12 cells and found 
that cAMP in combination with NGF had the same synergis- 
tic effect on early neurite outgrowth as shown above for its 
analogues (Fig. 4A). After 2 d in culture in the presence of 
cAMP (10  -3 M) and NGF, 80% of the cells exerted neuritic 
The Journal of Cell Biology, Volume  102.  1986  822 Figure 2. Effects of cAMP analogues on NGF-induced neurite outgrowth.  PC12 cells were exposed to NGF (50 ng/ml) and cAMP derivatives 
(10 -~ M) for 48 h. (a) Untreated control; (b) Bt2cAMP; (c) 2'-0-BtcAMP; (d) NGF; (e) NGF plus Bt2cAMP; (f) NGF plus 2'-0-BtcAMP; (g) 
NGF plus 6-CIcAMP; (h) NGF plus 8-BrcAMP; (i) NGF plus 8-PCTP.  Bar, 50 #m. 
823  Richter-Landsberg  and Jastorff  cAMP and Neuronal Differentiation Figure 3. Long term effect of cAMP analogues on neurite outgrowth. Cells were exposed to NGF and cAMP analogues (10  -3 M) for 6 d. (a) 
NGF alone; (b) Bt2cAMP alone; (c) 6-CIcAMP alone; (d) NGF plus 8-PCTP, (e) NGF plus 2'-0-BtcAMP; (.f) NGF plus BtzcAMP; (g) NGF 
plus 6-CIcAMP; (h) NGF plus 8-BrcAMP. Bar,  50 gin. 
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Figure 4. Time courses of appearance of 
neurites. PC 12 cells were exposed to NGF 
(50 ng/ml) and cAMP analogues ( 10  -3 M) 
simultaneously; forskolin was added at a 
concentration  of 10  -~ M. (A)O, NGF; (3, 
8-BrcAMP; A, cAMP; I, Bt2cAMP; (B) 
O,  Forskolin;  If,  2'-0-monobutyryl 
cAMP; O, 6-CIcAMP;  A, 8-BrcGMP; (C) 
©, GAB; l, (Sp)-cAMPS; A, 8-PCTP; O, 
(Rp)-cAMPS. Data represent the mean of 
triplicate experiments. 
Figure 5.  Effect of the cAMP antagonist (Rp)-cAMPS on NGF-mediated  neurite outgrowth. Phase micrographs are shown of PC 12 cells 
incubated for I d (a-c) or 3 d (d-f) with (a and d) NGF alone or (f) (Rp)-cAMPS (10  -3 M) alone; and in the simultaneous presence of NGF 
and (b and e) (Rp)-cAMPS (10  -3 M) or (c) (Sp)-cAMPS (10  -3 M). Bar, 50 t~m. 
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treated  cultures  (Fig.  4A).  cAMP  alone  did  not  produce 
neurites, yet in combined action with NGF not only increased 
neurite formation but also had a network stabilizing effect as 
observed in  cultures treated  for up to  6-8  d  (not  shown). 
Dose-response evaluation revealed a maximal effect of cAMP 
at a concentration of 10  -4 M, determined after 24 and 48 h 
of treatment. 
Effect of (Rp)-cAMPS 
The  simultaneous  addition  of the  cAMP  antagonist  (Rp)- 
cAMPS (10  -3 M) and NGF to the growth medium of PC12 
cells had no stimulatory or inhibitory action on NGF-induced 
process formation (Figs.  4C and  5).  Also,  preincubation of 
PCI2 cells in the presence of 10  -3 M (Rp)-cAMPS for up to 
3 d did not affect subsequent NGF-induced neurite outgrowth 
in the continued presence of (Rp)-cAMPS (data not shown). 
Thus, the cAMP antagonist (Rp)-cAMPS could not inhibit 
the  action  of NGF on  the  initiation  of neurite  outgrowth. 
However, when (Rp)-cAMPS was added to cultures contain- 
ing the cAMP agonist (Sp)-cAMPS and NGF, the potentiation 
of neurite outgrowth caused by the (Sp)-cAMPS diastereomer 
was markedly inhibited (Fig.  6). Quantitative evaluation in- 
dicated that the number of processes of PC 12 cells after 3 d 
in  NGF and  (Sp)-cAMPS  (10  -4  M)  was  decreased  in  the 
presence of (Rp)-cAMPS at concentrations of 10-* and  I0  -3 
M (Fig. 6). Thus indeed, the (Rp)-cAMPS derivative inhibited 
a  cAMP-specific effect in  PCI2 cells,  which was caused by 
the  exogenous addition  of cAMP analogues to the culture 
medium. Cellular viability was determined by exclusion of 
Trypan blue. In all cases cell death, after 72 h of incubation 
time did not exceed 7-10%. 
Uptake of (Sp)- and (Rp)-cAMPS by PC12 Cells 
The hydrophobicity of cAMP analogues has been extensively 
studied before and the (Sp)- and (Rp)-cAMPS diastereomers 
have been described to have similar physico-chemical char- 
acteristics (2).  When (Sp)-cAMPS was added to the culture 
medium  of PC12  cells at  a  concentration  of  10  -3  M  and 
aliquots of the cellular supernatant were analyzed by HPLC 
at various times, we found that after 72 h of incubation 23% 
of the exogenously applied (Sp)-cAMPS had disappeared from 
the medium (Fig.  7). Since PCI2 cells do not excrete phos- 
phodiesterase activity and the (Sp) isomer is stable in serum 
containing medium as well as in culture medium conditioned 
by  PC12  cells  for  72  h  (Richter-Landsberg,  C.,  and  Th. 
Braumann, manuscript in preparation), the metabolite found 









Figure  6.  Inhibitory  effect  of 
(Rp)-cAMPS  on  neurite  out- 
growth in PCI2 cells stimulated 
by the simultaneous presence of 
NGF and (Sp)-cAMPS. The per- 
centage  of  neurite  bearing 
clumps was analyzed in cultures 
exposed to  NGF  (O); 10  -3  M 
(Rp)-cAMPS plus NGF (1), 10  -4 
i  ~  3  M  (Sp)-cAMPS plus NGF (0); 
OAYS  NGF plus  10  4  M (Sp)-cAMPS 
simultaneously with  10  -4  M  (Rp)-cAMPS  (&);  and  10  -3  M  (r-l), 
respectively. Values are expressed as mean of a triplicate experiment. 
 oo, 
,  .l 
0  I  2  3 
time (cloys) 
Figure 7. Uptake of(Sp)-cAMPS and release of its metabolite AMPS- 
monophosphoric acid. (Sp)-cAMPS ( 1 raM) was added at day 0, and 
the cell supernatant was analyzed by HPLC at the indicated times. 
After 72 h of incubation time the concentration of (Sp)-cAMPS (x) 
had  reached  a  level  of 0.77  mM,  and  the  intracellularly formed 
metabolite AMPS-monophosphoric acid (0) was detectable in the 
cell supernatant. 
course of the uptake of (Rp)-cAMPS revealed identical results 
(not shown). However, no metabolite was found in the culture 
medium even after 72 h  of incubation,  sustaining previous 
findings, that this derivative is extremely stable against phos- 
phodiesterase activity (Braumann, Th., and B Jastorff, man- 
uscript in  preparation).  We could show by HPLC analysis 
that 3% of the (Rp)-cAMPS, which had entered the cells was 
extractable by sonication, whereas the rest remained tightly 
bound  to  the  cellular  pellet.  Thus,  the  phosphorothioates 
indeed  penetrate  PC I2  cellular  membranes and  therefore 
exert their differential action on  cAMP-dependent  protein 
kinases within PC 12 cells. 
Preliminary experiments indicate  that  in  PC12  cells the 
(Rp)-cAMPS derivative has an inhibitory effect on the cAMP- 
dependent phosphorylation of a 200-kD protein. This protein 
was found to be stimulated by Bt2cAMP and (Sp)-cAMPS at 
l0  -3 M after 24 h of incubation (Richter-Landsberg, C., un- 
published observations). 
Effect of Forskolin 
The adenylate cyclase activator forskolin has been described 
to  stimulate adenylate cyclase in  PCI2  cells and  raise the 
intracellular cAMP level by a factor of 50 at a concentration 
of 10  -6 M (26,  27).  We have analyzed the effect of forskolin 
on neurite formation at concentrations from 10  -1° to 10  -~ M. 
Forskolin  (10-7-10  -4  M)  alone,  like  BhcAMP,  caused  no 
formation of a neuritic network, but initiated 20-30% of the 
cells to extend short non-interlinking processes and to form 
large aggregates, as observed in cultures treated for up to 6-8 
d (Fig. 8 c). Exposure of PC12 cells to both NGF and forskolin 
produced a stimulation of process formation by far exceeding 
the  effect of NGF  or  forskolin  alone.  After  24  h  already 
70-80%  of the cells  had long interconnected  neurites (Fig. 
8 a) and a  neural network was formed within  3 d  (Fig.  8 b) 
and continuously elaborated after prolonged treatment with 
both agents (Fig. 8, dandf). Fig. 9 shows that a half maximal 
effect of forskolin occurs at 2 ×  10  -s M and a maximal effect 
occurs at 10  -6 M. The combined action of NGF and forskolin 
seemed  to  maintain  and  stabilized  the  neuronal  network 
elaborated by PC12 cells even better than NGF alone (Fig. 
The Journal of Cell Biology, Volume 102, 1986  826 Figure 8.  Potentiation of NGF-induced neurite outgrowth by forskolin. Phase micrographs are shown of PC12 cells exposed to (a,  b, and d) 
NGF plus forskolin (10  -5 M) for  1,  3,  and  6  d,  respectively. In c, cells were treated with forskolin alone (10  -5 M) for 6  d.  e and fdepict 
micrographs of cells treated with NGF (e) and with NGF plus forskolin (10  -6 M) (f) for 6 d. Bar, 50 um. 
2f).  It is interesting  to note that after incubation with high 
concentrations of forskolin (10-4-10  -5 M) PC I2 cell volume 
appeared to decrease and a shrinkage of  the cells was observed. 
At this high concentration long term neurite extension (>6 d) 
was  inhibited  and  many of the  neurites  failed  to establish 
growth cone-like structures.  In contrast, at lower concentra- 
tions of forskolin (<10  -6 M), cells seemed to rather increase 
their volume. Cultures treated with forskolin contained many 
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Figure 9  Dose response relationship of forskotin on NGF-induced 
neurite outgrowth in PC I2 cells. Cells were incubated with increasing 
concentrations of forskolin (O),  or forskolin plus NGF (e) for 24 h. 
The  value for  NGF  alone at this time  point  was  23%.  Numbers 
represent mean percentage of triplicate experiments. 
giant cells with long branched neurites, as has been observed 
also for 8-BrcAMP. 
Discussion 
The aim of this study was to investigale further the role of 
cAMP on  NGF-mediated neurite outgrowth in PC12  cells. 
The data  indicate  that a  specific cAMP effect is observed 
during the treatment of PC12 cells with cAMP, its analogues 
or the potent adenylate cyclase activator forskolin. However, 
cAMP does not act as a second messenger for NGF-induced 
neurite outgrowth, as has been discussed (6,  15, 32, 33). This 
conclusion is based on the  following evidence:  (a) Neither 
forskolin  nor cAMP or its analogues induced  neurite  out- 
growth to  the  same extent as NGF.  (b) The simultaneous 
addition  of NGF and cAMP analogues or forskolin poten- 
tialed  neurite  outgrowth  in  PC12  cells synergistically, thus 
indicating that they act through differential mechanisms. (c) 
The cAMP antagonist (Rp)-cAMPS did not exert inhibitory 
actions on NGF-induced process formation in PCI2 ceIIs. (d) 
The synergistic potentiation of neurite outgrowth produced 
by the simultaneous addition of NGF and the cAMP agonist 
(Sp)-cAMPS  was  successfully inhibited  by the  addition  of 
(Rp)-cAMPS, and neurite outgrowth was repressed almost to 
the level normally seen with NGF alone. The (Rp)-cAMPS 
analogue neither alone nor in combination with NGF exerts 
any morphological changes or synergistic effects in PC 12 cells. 
(Rp)-cAMPS has previously been described to compete with 
cAMP for the binding to the regulatory subunit of protein 
kinases (4,  24).  Upon binding,  the  release of the  catalytic 
subunit is inhibited,  and therefore the activation of cAMP- 
dependent protein kinases is blocked (4). This has been dem- 
onstrated for protein kinases of rat hepatocytes (30, 31). (Rp)- 
cAMPS  has  also been  shown  to  inhibit  cAMP-induced  in 
vitro  phosphorylation  of microtubule-associated  protein  2 
(MAP2) in microtubules prepared from beef  brain (28). NGF- 
induced neurite formation was not inhibited by this deriva- 
tive. This indicates that cAMP activation of protein kinases 
is neither sufficient nor necessary for NGF-induced neurite 
outgrowth in PC 12 cells. It is, however, conceivable that the 
constant application of agents that increase the intracellular 
levels of cAMP indirectly trigger NGF-like responses. 
We  have  found  that  cAMP  itself added  to  the  culture 
medium  stimulates  NGF-induced  neurite  outgrowth,  al- 
though the polarity of the molecule and metabolizing enzy- 
matic activities supposedly impede its  passage through  the 
cellular membrane (25). In recent years, cAMP receptors have 
been  identified  in  mammalian brain  in  cytosol as well  as 
membrane fractions (37).  In  neuroblastoma-glioma hybrid 
cells Walter et at. (36)  have identified free type I regulatory 
subunit and demonstrated its regulation by Bt2cAMP.  The 
possibility was discussed that cAMP receptor proteins have 
additional functions apart from inhibiting the catalytic sub- 
unit of protein kinases and may regulate cellular functions 
such  as growth and differentiation (36).  One might further 
hypothesize that cAMP acts as a regulator of differentiation 
of nerve ceils.  Sympathetic neurons and adrenal medullary 
ceils originate from the neural crest and thus have common 
precursors. PCI2 cells under normal growth conditions are 
considered to represent the neoplastic counterpart of adrenal 
chromaffin cells, and in the presence of NGF they resemble 
sympathetic neurons (9). cAMP has been described as having 
differential effects on NGF-induced neurite outgrowth from 
adrenal medullary chromaffin cells, sympathetic neurons, and 
PC12 cells (39).  These authors showed that Bt2cAMP,  theo- 
phylline, or cholera toxin in combination with NGF enhanced 
neurite  outgrowth in  PC12  cells  and  sympathetic neurons, 
whereas process formation from chromaffin cells under the 
same conditions  was suppressed (39).  Thus,  the  combined 
presence of NGF and cAMP may influence the developmental 
expression of neural crest derived cells to either become the 
neuronal or adrenal phenotype. 
Two major effects of NGF have been discussed:  first, a slow 
and transcription-dependent process, providing the synthesis 
of  proteins necessary for the formation and growth of neurites, 
and second, a fast and transcription-independent process. This 
fast process may regulate the state of assembly and the activity 
and  organization  of  these  yet  unidentified  proteins  and 
thereby promote neurite outgrowth (7,  10). The latter process 
might be related to the action of cAMP. Neurile initiation by 
NGF from PCI2 cells requires RNA symhes~s, whereas hen- 
rite  regeneration  of "primed" cells  is  a  transcription-inde- 
pendent  process  (3).  PC12  cells  cannot  be  primed  by 
Bt2cAMP,  yet the  simultaneous addition  of Bt2cAMP  and 
NGF enables the cells to initiate neurite outgrowth by a RNA- 
synthesis independent mechanism (13,  14,  16). Thus, primed 
cells  as well as cells treated  with  NGF and  Bt2cAMP  can 
respond rapidly to NGF for regenerative or plastic processes. 
We have found that although after 6-8 d of treatment with 
NGF alone or in the presence of NGF plus cAMP analogues 
or forskolin, the maximal percentage of neurite-bearing cells 
was reached  under both conditions;  the  neuronal network, 
however,  was  better  maintained  and  more  extensively 
branched in the presence of the combined treatment. Hence, 
cAMP was  not  necessary for the  initiation  of neurite  out- 
growth but helped to stabilize and maintain established con- 
nections. 
cAMP or its analogues exerted their morphological effects 
at relatively high,  unphysiological concentrations,  requiring 
the continued presence of the agents. It has to be taken into 
consideration that cAMP metabolites may be produced dur- 
ing the long incubation and may induce specific physiological 
events during the differentiation of PC 12 cells. These ques- 
tions are currently under investigation in our laboratory. 
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